News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Sanofi Receives European Commission Approval for Sarclisa Combination Therapy in Newly Diagnosed Multiple Myeloma
Monday, November 17, 2025Sanofi gains European Commission approval for Sarclisa in combination with VRd for newly diagnosed multiple myeloma patients
Alvotech Accelerates European Leadership with Multiple EMA Biosimilar Approvals, Strong Q3 Performance, and Expansion of Packaging Capabilities in 2025
Friday, November 14, 2025Alvotechs Q results highlight major biosimilar approvals in Europe significant revenue growth and enhanced manufacturing capabilities through key acquisitions
Numab Therapeutics and Kaken Pharmaceutical sign licence and co-development agreement for multispecific antibody NM81 in inflammatory bowel disease (IBD)
Friday, November 14, 2025Numab Therapeutics AG a biotechnology firm developing multispecific antibodies in immunology and oncology has entered a licence and codevelopment agreement with Kaken Pharmaceutical for NM
European Patent Office Grants Tenax Therapeutics Landmark Patent for Levosimendan in PH-HFpEF, Paving Way for European Phase 3 Expansion
Thursday, November 13, 2025Tenax Therapeutics secures European protection for levosimendan in pulmonary hypertension with heart failure advancing pivotal trials
Chiesi Group Signs Exclusive Licence Agreement with Aliada Therapeutics to Advance Blood–Brain Barrier Technology for Lysosomal Storage Disorders
Thursday, November 13, 2025Chiesi Group has entered into an exclusive licence agreement with Aliada Therapeutics a wholly owned subsidiary of AbbVie to develop bloodbrain barrier BBBcrossing platform technology for treating lysosomal storage disorders
Evotec Receives Milestone Payment From Bristol Myers Squibb Following IND Acceptance In Strategic Protein Degradation Partnership
Wednesday, November 12, 2025Evotec has received a million milestone payment from Bristol Myers Squibb after FDA acceptance of an investigational new drug application in their Europeanbased protein degradation partnership
KalVista Pharmaceuticals Initiates First European Launch of EKTERLY® for Hereditary Angioedema in Germany Following EU Approval
Tuesday, November 11, 2025KalVista Pharmaceuticals has begun distribution of EKTERLY the first oral ondemand hereditary angioedema therapy in Germany following recent European regulatory approval
Novartis Opens New Radioligand Therapy Manufacturing Plant in California as Part of $23 Billion US Expansion Plan
Tuesday, November 11, 2025Novartis a global leader in innovative medicines has opened a new squarefoot radioligand therapy RLT manufacturing plant in Carlsbad California The facility marks a major step in the companys billion investment
European Union Launches Ambitious Life Science Strategy to Bolster Innovation and Global Competitiveness by 2030
Monday, November 10, 2025The European Commission today launched a transformative life science strategy to strengthen EU innovation market access and competitiveness by
Urteste S.A. launches European multicenter clinical study of the Panuri test
Friday, November 07, 2025Urteste SA begins a multicenter clinical trial in Europe for its noninvasive Panuri test to detect pancreatic cancer collaborating with Aurevia in Poland Hungary and Italy
